Sanara MedTech Inc. Announces Annual Meeting of Shareholders

TL;DR

Sanara MedTech Inc. will hold its Annual Meeting of Shareholders virtually on June 12, 2024, requiring advance registration for online participation.

AI Summary

Sanara MedTech Inc. (SMTI) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. The Annual Meeting of Shareholders for Sanara MedTech Inc. will be held virtually on June 12, 2024, at 10:00 a.m. Central Time. Shareholders must register in advance by June 11, 2024, at 8:00 p.m. Central Time to participate virtually. The meeting will be conducted exclusively online via the Internet, with no in-person attendance option. The proxy statement and 2023 Annual Report, including audited financial statements, are enclosed. Shareholders are encouraged to vote in advance via the Internet, email, facsimile, or by returning the proxy card.

Why It Matters

For investors and stakeholders tracking Sanara MedTech Inc., this filing contains several important signals. The virtual-only format necessitates advance registration, potentially impacting shareholder participation if deadlines are missed. The company emphasizes the importance of shareholder votes, regardless of share quantity, highlighting the need for active participation in corporate governance.

Risk Assessment

Risk Level: low — Sanara MedTech Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual shareholder meeting and does not contain new financial or operational information that would indicate significant risk.

Analyst Insight

Shareholders should review the proxy statement and vote their shares in advance of the June 11, 2024 deadline to ensure their participation in corporate decisions.

Key Numbers

• June 12, 2024 — Annual Meeting Date (Annual Meeting of Shareholders)
• 10:00 a.m. Central Time — Annual Meeting Time (Annual Meeting of Shareholders)
• June 11, 2024 — Registration Deadline (To participate in the Annual Meeting virtually)
• 8:00 p.m. Central Time — Registration Deadline Time (To participate in the Annual Meeting virtually)

Key Players & Entities

• Sanara MedTech Inc. (company) — Registrant name
• June 12, 2024 (date) — Date of Annual Meeting
• June 11, 2024 (date) — Registration deadline
• 817-529-2300 (phone) — Business phone number
• 1200 Summit Ave Suite 414 Fort Worth, Texas 76102 (address) — Business address

FAQ

Industry Context

Sanara MedTech Inc. operates in the orthopedic, prosthetic, and surgical appliances & supplies industry.

Regulatory Implications

The filing is a Definitive Proxy Statement (DEF 14A) filed under the Securities Exchange Act of 1934, requiring specific disclosures for shareholder meetings.

What Investors Should Do

1. Review the Proxy Statement for details on proposals and voting matters.
2. Register for the virtual Annual Meeting by June 11, 2024.
3. Vote shares in advance using the provided proxy card or online options.

Key Dates

• 2024-06-12: Annual Meeting of Shareholders — Shareholders will vote on company matters and hear updates.
• 2024-06-11: Registration Deadline for Virtual Meeting — Last chance for shareholders to register to attend the virtual meeting.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard proxy statement for an annual shareholder meeting. No comparative financial or operational data is presented in this document.

Key Financial Figures

• $0.001 — holders of our common stock, par value $0.001 per share. The accompanying proxy is

Filing Documents

• formdef14a.htm (DEF 14A) — 943KB
• logo_001.jpg (GRAPHIC) — 11KB
• chart_001.jpg (GRAPHIC) — 338KB
• chart_002.jpg (GRAPHIC) — 343KB
• 0001493152-24-014548.txt ( ) — 1898KB

BUSINESS

BUSINESS 51 SUBMISSION OF FUTURE SHAREHOLDER PROPOSALS 51 ANNEX A: PROPOSED FORM OF AMENDED AND RESTATED CERTIFICATE OF FORMATION A-1 ANNEX B: MARKED VERSION OF PROPOSED FORM OF AMENDED AND RESTATED CERTIFICATE OF FORMATION B-1 ANNEX C: PROPOSED FORM OF THE SANARA MEDTECH INC. 2024 LONG-TERM INCENTIVE PLAN C-1 SANARA MEDTECH INC. 1200 Summit Ave Suite 414 Fort Worth, Texas 76102 (817) 529-2300 PROXY FOR ANNUAL MEETING OF SHAREHOLDERS To Be Held June 12, 2024 Unless the context otherwise requires, references in this proxy statement (this “Proxy Statement”) to “Sanara MedTech,” “Sanara,” the “Company,” “we,” “us,” or “our” refer to Sanara MedTech Inc., a Texas corporation, and its consolidated subsidiaries as a whole. In addition, unless the context otherwise requires, references to “shareholders” are to the holders of our common stock, par value $0.001 per share. The accompanying proxy is solicited by the Board of Directors (the “Board”) on behalf of Sanara MedTech Inc. to be voted at the 2024 annual meeting of shareholders of the Company (the “Annual Meeting”) to be held on June 12, 2024, at the time and place and for the purposes set forth in the accompanying Notice of Annual Meeting of Shareholders and at any postponement(s) or adjournment(s) of the Annual Meeting. The Notice of Internet Availability of Proxy Materials, or this Proxy Statement and the accompanying proxy card, Notice of Annual Meeting of Shareholders and Annual Report for the year ended December 31, 2023 (the “Annual Report”), as applicable, are expected to be first sent or given to shareholders on or about April 26, 2024. The executive offices of the Company are located at, and the mailing address of the Company is, 1200 Summit Ave, Suite 414, Fort Worth, Texas 76102. 1 ABOUT THE ANNUAL MEETING What is a proxy? A

View Full Filing

View this DEF 14A filing on SEC EDGAR